ID: ALA4647483

Max Phase: Preclinical

Molecular Formula: C32H26Cl4O2

Molecular Weight: 584.37

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=CCc1ccc(OCc2ccc(Cl)c(Cl)c2)c(-c2ccc(OCc3ccc(Cl)c(Cl)c3)c(CC=C)c2)c1

Standard InChI:  InChI=1S/C32H26Cl4O2/c1-3-5-21-9-13-32(38-20-23-8-12-28(34)30(36)17-23)26(15-21)24-10-14-31(25(18-24)6-4-2)37-19-22-7-11-27(33)29(35)16-22/h3-4,7-18H,1-2,5-6,19-20H2

Standard InChI Key:  UZCHYXGIBXMEAC-UHFFFAOYSA-N

Associated Targets(Human)

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CNE2Z 34 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

I10 29 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 584.37Molecular Weight (Monoisotopic): 582.0687AlogP: 10.58#Rotatable Bonds: 11
Polar Surface Area: 18.46Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 2HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 11.37CX LogD: 11.37
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.16Np Likeness Score: -0.20

References

1. Zhu M, Li B, Ma H, Huang X, Wang H, Dai Y, Li Y, Li HM, Wu CZ..  (2020)  Synthesis and in vitro antitumor evaluation of honokiol derivatives.,  30  (2): [PMID:31831382] [10.1016/j.bmcl.2019.126849]

Source